Journal of Clinical Epidemiology
Volume 59, Issue 3 , Pages 217-223 , March 2006

Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions

,Accepted 18 July 2005.

References 

  1. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728–1733
  2. Grieve AP. The number needed to treat: a useful clinical measure or a case of the Emperor's new clothes?. Pharmaceut Stat. 2003;2:87–102
  3. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. [Review] Lancet. 1990;335:827–838
  4. Rajkumar SV, Sampathkumar P, Gustafson AB. Number needed to treat is a simple measure of treatment efficacy for clinicians. J Gen Intern Med. 1996;11:357–359
  5. Scandinavian Simvastatin Survival Study Group [SSSSG] . Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1995;344:1383–1389
  6. Bell DM. Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes. Pharmacotherapy. 1999;19:1086–1093
  7. Rembold CM. Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy. J Fam Pract. 1996;42:577–586
  8. Van de Werf F. Mortality results in GUSTO. Aust N Z J Med. 1993;23:732–734
  9. Skolbekken JA. Communicating the risk reduction achieved by cholesterol reducing drugs. [Review] BMJ. 1998;316:1956–1958
  10. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307
  11. Pearce KA, Furberg CD, Psaty BM, Kirk J. Cost-minimization and the number needed to treat in uncomplicated hypertension. Am J Hypertens. 1998;11:618–629
  12. Walter SD. Number needed to treat (NNT): estimation of a measure of clinical benefit. Stat Med. 2001;20:3947–3962
  13. Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials. 2001;22:102–110
  14. Sun J, Song PXK. Statistical analysis of repeated measurements with informative censoring times. Stat Med. 2001;20:63–73
  15. Newcombe RG. Know your limitations: not just for clinicians: estimation of confidence intervals is not straightforward. J Public Health Med. 1999;21:481–482
  16. Bickel P, Docksum K. Mathematical statistics. San Francisco: Holden-Day; 1977;

PII: S0895-4356(05)00247-7

doi: 10.1016/j.jclinepi.2005.07.006

Journal of Clinical Epidemiology
Volume 59, Issue 3 , Pages 217-223 , March 2006

Article Tools

* Image Usage & Resolution